Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-028269
Filing Date
2025-02-27
Accepted
2025-02-27 06:01:13
Documents
1
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 13404
  Complete submission text file 0000950170-25-028269.txt   14907
Mailing Address C/O TOKAI PHARMACEUTICALS, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Kalowski Lee (Reporting) CIK: 0001618273 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38433 | Film No.: 25672557

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Issuer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)